Panelists discuss how integrating metabolic, pharmacologic, and multidisciplinary strategies can bridge the obesity–MASH divide to improve early detection, treatment outcomes, and long-term public health impact.
EP. 1: Understanding the Metabolic–Hepatic Connection in MASH
Panelists discuss how metabolic dysfunction drives liver injury, highlighting early recognition of the obesity–MASH connection as key to prevention.
Watch
EP. 2: Enhancing Early Detection and Diagnosis in MASH
Panelists discuss how structured, multidisciplinary screening efforts can catch MASH earlier and prevent progression.
Watch
EP. 3: Recognizing Risk and the Broader Health Impact in MASH
Panelists discuss how recognizing high-risk patients and linking liver care with metabolic management can reduce both disease and economic impact.
Watch
EP. 5: Expanding the Therapeutic Horizon in MASH
Panelists discuss how next-generation metabolic and hepatic agents are broadening treatment options and reshaping the MASH care landscape.
Watch
EP. 6: Balancing Clinical and Economic Considerations in Treatment Adoption
Panelists discuss how integrating clinical efficacy with cost-effectiveness ensures sustainable adoption of MASH therapies.
Watch